文献速递心血管US

二尖瓣脱垂伴二尖瓣环分离:表现与结局

The Mitral Annular Disjunction of Mitral Valve Prolapse: Presentation and Outcome.
PubMed 文献 · JACC Cardiovasc Imaging · 2021-06-16

本研究纳入595例孤立性二尖瓣脱垂患者,评估二尖瓣环分离的患病率、表型特征及长期结局。二尖瓣环分离患病率为31%(186例),独立与严重黏液样病变(双叶脱垂和瓣叶冗余)及左心室较大相关。二尖瓣环分离与临床心律失常事件风险升高独立相关(校正HR 2.60),但诊断后10年内未发现全因死亡率增加。

要点

  • 二尖瓣脱垂患者中二尖瓣环分离常见(31%),多见于年轻患者,独立关联双叶脱垂和瓣叶冗余。
  • 二尖瓣环分离独立关联心律失常事件风险升高(校正HR 2.60,95%CI 1.87-3.62)。
  • 诊断后10年内二尖瓣环分离未关联超额死亡率,但需警惕心律失常。

核心结论

  • 二尖瓣脱垂诊断时二尖瓣环分离常见,与晚期黏液样变性独立相关,并独立关联长期临床心律失常事件发生率增加;但诊断后10年内未发现超额死亡率。

研究设计与样本

  • 回顾性队列研究,纳入595例连续孤立性二尖瓣脱垂患者(278例女性,平均年龄61±16岁),进行临床、心律、多普勒超声心动图及一致性二尖瓣环分离评估,并行倾向性评分匹配平衡基线差异。

诊断标准与关键数值

  • 二尖瓣环分离患病率为31%(186/595)。
  • 二尖瓣环分离独立关联严重黏液样病变(双叶脱垂和显著瓣叶冗余,均P≤0.0002)及较大左心室(P=0.005)。
  • 二尖瓣环分离独立关联心律失常事件风险升高(校正HR 2.60,95%CI 1.87-3.62,P<0.0001)。
  • 二尖瓣环分离与心律失常事件的关联在时间依赖性二尖瓣手术分析中持续存在(校正HR 2.54,95%CI 1.84-3.50,P<0.0001);药物治疗下关联更强(校正HR 3.21,95%CI 2.03-5.06,P<0.0001),二尖瓣手术后关联较弱(校正HR 2.07,95%CI 1.24-3.43,P=0.005)。
  • 二尖瓣脱垂诊断后10年生存率:无二尖瓣环分离者93%±2%,有二尖瓣环分离者97%±1%(P=0.40)。

临床应用与阅片要点

  • 二尖瓣脱垂患者超声评估时应关注二尖瓣环分离,尤其双叶脱垂和瓣叶冗余者。
  • 检出二尖瓣环分离提示需监测心律失常事件,但生存预后未显示恶化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aim of this study was to assess in patients with mitral valve prolapse (MVP) mitral annular disjunction (MAD) prevalence, phenotypic characteristics, and long-term outcomes (clinical arrhythmic events and excess mortality).

BACKGROUND: Clinical knowledge regarding MAD of MVP remains limited and controversial, and its potential link with untoward outcomes is unsubstantiated.

METHODS: A cohort of 595 (278 women, mean age 61 ± 16 years) consecutive patients with isolated MVP, with comprehensive clinical, rhythmic, Doppler echocardiographic, and consistent MAD assessment, were examined. MAD prevalence, associated MVP phenotypes, and outcomes (survival, clinical arrhythmic events) starting at diagnostic echocardiography were analyzed. To balance important baseline differences, propensity scoring matching was conducted among patients with and those without MAD.

RESULTS: The presence of MAD was common (n = 186 [31%]) in patients with MVP, generally in younger patients, and was not random but was independently associated with severe myxomatous disease involving bileaflet MVP and marked leaflet redundancy (both P ≤ 0.0002). The presence of MAD was also independently associated with a larger left ventricle (P = 0.005). Age-matched cohort survival after MVP diagnosis was not worse with MAD (10-year survival 93% ± 2% for patients without MAD and 97% ± 1% for those with MAD; P = 0.40), even adjusted comprehensively for MVP characteristics (P = 0.80) and accounting for time-dependent mitral surgery (P = 0.60). During follow-up, 170 patients had clinical arrhythmic events (ventricular tachycardia, n = 159; arrhythmia ablation, n = 14; cardioverter-defibrillator implantation, n = 14; sudden cardiac death, n = 3). MAD was independently associated with higher risk for arrhythmic events (adjusted HR: 2.60; 95% CI: 1.87-3.62; P < 0.0001). The link between MAD and arrhythmic events persisted with time-dependent mitral surgery (adjusted HR: 2.54; 95% CI: 1.84-3.50; P < 0.0001), was strong under medical management (adjusted HR: 3.21; 95% CI: 2.03-5.06; P < 0.0001) but was weaker after mitral surgery (adjusted HR: 2.07; 95% CI: 1.24-3.43; P = 0.005).

CONCLUSIONS: This large cohort with MVP comprehensively characterized shows that MAD is frequent at MVP diagnosis and is strongly linked to advanced myxomatous degeneration. The presence of MAD was independently associated with long-term excess incidence of clinical arrhythmic events. However, within the first 10 years post-diagnosis, MAD was not linked to excess mortality, and although reassurance should be provided from the survival point of view, careful monitoring for arrhythmias is in order for MAD.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Essayagh B, Sabbag A, Antoine C, et al. The Mitral Annular Disjunction of Mitral Valve Prolapse: Presentation and Outcome. JACC Cardiovasc Imaging. 2021. PMID: 34147457. doi:10.1016/j.jcmg.2021.04.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。